Pub Date : 2026-01-01Epub Date: 2025-10-02DOI: 10.1097/DBP.0000000000001424
Nicole M Talge, Sarah A Keim, Samrawit F Yisahak, Ursula M Findlen, Lindsey Kovacs Bechtold, Brooke Ingersoll
Objective: Problems with hearing feature prominently in autism spectrum disorder (ASD) but remain poorly characterized within population-based samples and according to symptom heterogeneity.
Method: We analyzed cross-sectional, caregiver-reported data from the National Survey of Children's Health (2016-2020). Our US-based sample included children with data on the presence/absence of "deafness or problems with hearing" (DPHs) and ASD (ages 3-17 years; n = 150,327). We used weighted logistic regression to examine the association between DPHs and (1) ASD diagnosis (no, yes), (2) ASD symptom severity (none, mild, moderate/severe), and (3) co-occurrences of ASD with intellectual disability (ID) (neither, ASD only, ID only, both) or attention deficit/hyperactivity disorder (ADHD) (neither, ADHD only, ADHD only, both). We also assessed effect modification by sex and preterm birth.
Results: Deafness or problems with hearing were associated with greater odds of ASD (OR = 2.7; 95% CI, 1.8-3.9), with 4% of children with ASD having DPHs versus 1% of children without ASD. Associations were stronger for: moderate/severe ASD symptoms (OR = 3.5; 95% CI, 2.1-5.7) versus mild symptoms (OR = 1.8; 95% CI, 1.1-3.1); children with co-occurring ID (OR = 5.0; 95% CI, 2.8-9.0) or ID only (OR = 8.6; 95% CI, 6.0-12.4); and children with co-occurring ADHD (OR = 4.3; 95% CI, 2.5-7.2) than for ASD only. Findings persisted after adjustment and were stronger for females versus males but were not modified by preterm birth.
Conclusion: Deafness or problems with hearing are associated with ASD, particularly-though not exclusively among children with more severe symptoms and co-occurring ID. Future research is needed to determine whether DPHs in ASD are driven by sensory, cognitive, and/or motivational processes or residual confounding (e.g., congenital anomalies).
{"title":"Deafness and Hearing Problems and Their Association With Autism Spectrum Disorder Diagnosis and Symptoms.","authors":"Nicole M Talge, Sarah A Keim, Samrawit F Yisahak, Ursula M Findlen, Lindsey Kovacs Bechtold, Brooke Ingersoll","doi":"10.1097/DBP.0000000000001424","DOIUrl":"https://doi.org/10.1097/DBP.0000000000001424","url":null,"abstract":"<p><strong>Objective: </strong>Problems with hearing feature prominently in autism spectrum disorder (ASD) but remain poorly characterized within population-based samples and according to symptom heterogeneity.</p><p><strong>Method: </strong>We analyzed cross-sectional, caregiver-reported data from the National Survey of Children's Health (2016-2020). Our US-based sample included children with data on the presence/absence of \"deafness or problems with hearing\" (DPHs) and ASD (ages 3-17 years; n = 150,327). We used weighted logistic regression to examine the association between DPHs and (1) ASD diagnosis (no, yes), (2) ASD symptom severity (none, mild, moderate/severe), and (3) co-occurrences of ASD with intellectual disability (ID) (neither, ASD only, ID only, both) or attention deficit/hyperactivity disorder (ADHD) (neither, ADHD only, ADHD only, both). We also assessed effect modification by sex and preterm birth.</p><p><strong>Results: </strong>Deafness or problems with hearing were associated with greater odds of ASD (OR = 2.7; 95% CI, 1.8-3.9), with 4% of children with ASD having DPHs versus 1% of children without ASD. Associations were stronger for: moderate/severe ASD symptoms (OR = 3.5; 95% CI, 2.1-5.7) versus mild symptoms (OR = 1.8; 95% CI, 1.1-3.1); children with co-occurring ID (OR = 5.0; 95% CI, 2.8-9.0) or ID only (OR = 8.6; 95% CI, 6.0-12.4); and children with co-occurring ADHD (OR = 4.3; 95% CI, 2.5-7.2) than for ASD only. Findings persisted after adjustment and were stronger for females versus males but were not modified by preterm birth.</p><p><strong>Conclusion: </strong>Deafness or problems with hearing are associated with ASD, particularly-though not exclusively among children with more severe symptoms and co-occurring ID. Future research is needed to determine whether DPHs in ASD are driven by sensory, cognitive, and/or motivational processes or residual confounding (e.g., congenital anomalies).</p>","PeriodicalId":50215,"journal":{"name":"Journal of Developmental and Behavioral Pediatrics","volume":"47 1","pages":"e26-e32"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Musical hallucinations are a rare auditory phenomenon, with fewer than 50 pediatric cases reported in the literature. They are particularly uncommon in children without hearing impairment or psychosis.
Case presentation: A Thai girl with ADHD, diagnosed at age 5 years and treated with methylphenidate, presented with a 1-week history of bilateral musical hallucinations. The hallucinations consisted of instrumental music without lyrics, were nonpulsatile, occurred predictably during specific hours, and were emotionally distressing. Audiologic evaluation showed normal hearing bilaterally, and EEG showed normal background activity with no epileptiform changes during hallucination episodes. She also exhibited frequent eye blinking consistent with simple motor tics. Developmental assessment revealed some developmental delays, with a KBIT-2 composite IQ of 87, showing a moderate discrepancy between verbal (79) and nonverbal (98) domains, potentially reflecting both neurodevelopmental vulnerabilities and sociolinguistic factors. Initial nonpharmacological interventions including media restriction and behavioral techniques were unsuccessful. Low-dose risperidone (0.25 mg/day) led to complete resolution of hallucinations, tics, and associated emotional distress within 3 weeks. She remained symptom-free at the 3-month follow-up.
Conclusion: Musical hallucinations can occur in children with ADHD even in the absence of hearing impairment, epilepsy, or psychosis. Early recognition, comprehensive evaluation, and multidisciplinary management are essential. When symptoms cause significant distress, low-dose risperidone may be an effective treatment. Recognizing the structured and nonpsychotic nature of musical hallucination in neurodevelopmental contexts may help avoid misdiagnosis and guide appropriate intervention.
{"title":"Musical Hallucinations in a Preadolescent With ADHD: A Case Report.","authors":"Nonglak Boonchooduang, Maniwan Phetsena, Nisochol Mekpoti, Orawan Louthrenoo","doi":"10.1097/DBP.0000000000001441","DOIUrl":"10.1097/DBP.0000000000001441","url":null,"abstract":"<p><strong>Background: </strong>Musical hallucinations are a rare auditory phenomenon, with fewer than 50 pediatric cases reported in the literature. They are particularly uncommon in children without hearing impairment or psychosis.</p><p><strong>Case presentation: </strong>A Thai girl with ADHD, diagnosed at age 5 years and treated with methylphenidate, presented with a 1-week history of bilateral musical hallucinations. The hallucinations consisted of instrumental music without lyrics, were nonpulsatile, occurred predictably during specific hours, and were emotionally distressing. Audiologic evaluation showed normal hearing bilaterally, and EEG showed normal background activity with no epileptiform changes during hallucination episodes. She also exhibited frequent eye blinking consistent with simple motor tics. Developmental assessment revealed some developmental delays, with a KBIT-2 composite IQ of 87, showing a moderate discrepancy between verbal (79) and nonverbal (98) domains, potentially reflecting both neurodevelopmental vulnerabilities and sociolinguistic factors. Initial nonpharmacological interventions including media restriction and behavioral techniques were unsuccessful. Low-dose risperidone (0.25 mg/day) led to complete resolution of hallucinations, tics, and associated emotional distress within 3 weeks. She remained symptom-free at the 3-month follow-up.</p><p><strong>Conclusion: </strong>Musical hallucinations can occur in children with ADHD even in the absence of hearing impairment, epilepsy, or psychosis. Early recognition, comprehensive evaluation, and multidisciplinary management are essential. When symptoms cause significant distress, low-dose risperidone may be an effective treatment. Recognizing the structured and nonpsychotic nature of musical hallucination in neurodevelopmental contexts may help avoid misdiagnosis and guide appropriate intervention.</p>","PeriodicalId":50215,"journal":{"name":"Journal of Developmental and Behavioral Pediatrics","volume":" ","pages":"e33-e36"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146031554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-10-10DOI: 10.1097/DBP.0000000000001425
Allison E Gornik, Benjamin J Schindel, Amanda Kim, Mwuese Ngur, T Andrew Zabel, Carmen Lopez-Arvizu, Suzanne Rybczynski, Paul H Lipkin
Objective: This naturalistic, observational study aimed to assess the frequency and timing of new and recent suicidal ideation (SI) in youth with neurologic, developmental, and behavioral disorders (NDBDs) after an initial negative suicide risk screening within medical and behavioral health settings.
Method: A total of 5030 children aged 8 to 17 years were included, all of whom received at least 2 routine suicide risk screenings between July 2019 and February 2024 as part of their larger clinical care appointments (N = 20,177 total screenings). Screenings were conducted using the Ask Suicide-Screening Questions tool. Analyses examined the interval between an initial negative screening and the emergence of new SI, with stratification by clinic type and age group. Predictors of new onset of SI were also examined.
Results: Overall, a significant proportion of children screened positive for new SI after an initial negative screening (8.4%). Rates were higher in behavioral health clinics (11.3%) compared with medical clinics (5.4%), with a median interval of 5 to 6 months to the first positive screening for both settings. Females were more likely to report new SI, as were those in seen in behavioral health as compared with medical clinics.
Conclusion: The findings highlight the importance of repeated suicide risk screening in children with NDBDs as a significant proportion of new SI is reported in the months after an initial negative screening. Screening only annually appears likely to underdetect risk, underscoring the need for more frequent screening particularly within the first year of care to improve early detection and intervention opportunities.
{"title":"New Onset of Suicidal Ideation in Children With Neurologic, Developmental, and Behavioral Disorders From Longitudinal Universal Suicide Risk Screening.","authors":"Allison E Gornik, Benjamin J Schindel, Amanda Kim, Mwuese Ngur, T Andrew Zabel, Carmen Lopez-Arvizu, Suzanne Rybczynski, Paul H Lipkin","doi":"10.1097/DBP.0000000000001425","DOIUrl":"10.1097/DBP.0000000000001425","url":null,"abstract":"<p><strong>Objective: </strong>This naturalistic, observational study aimed to assess the frequency and timing of new and recent suicidal ideation (SI) in youth with neurologic, developmental, and behavioral disorders (NDBDs) after an initial negative suicide risk screening within medical and behavioral health settings.</p><p><strong>Method: </strong>A total of 5030 children aged 8 to 17 years were included, all of whom received at least 2 routine suicide risk screenings between July 2019 and February 2024 as part of their larger clinical care appointments (N = 20,177 total screenings). Screenings were conducted using the Ask Suicide-Screening Questions tool. Analyses examined the interval between an initial negative screening and the emergence of new SI, with stratification by clinic type and age group. Predictors of new onset of SI were also examined.</p><p><strong>Results: </strong>Overall, a significant proportion of children screened positive for new SI after an initial negative screening (8.4%). Rates were higher in behavioral health clinics (11.3%) compared with medical clinics (5.4%), with a median interval of 5 to 6 months to the first positive screening for both settings. Females were more likely to report new SI, as were those in seen in behavioral health as compared with medical clinics.</p><p><strong>Conclusion: </strong>The findings highlight the importance of repeated suicide risk screening in children with NDBDs as a significant proportion of new SI is reported in the months after an initial negative screening. Screening only annually appears likely to underdetect risk, underscoring the need for more frequent screening particularly within the first year of care to improve early detection and intervention opportunities.</p>","PeriodicalId":50215,"journal":{"name":"Journal of Developmental and Behavioral Pediatrics","volume":" ","pages":"e19-e25"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-10-03DOI: 10.1097/DBP.0000000000001429
Abigail S Robbertz, Cecelia I Nelson, James Peugh, Kevin Hommel, Lisa P Armistead, Lindsey L Cohen
Objectives: For youth with gastrointestinal (GI) conditions, mental health symptoms can exacerbate GI symptoms. In a cyclical fashion, experiencing GI symptoms at school can contribute to depression, anxiety, and embarrassment. This study evaluated the impact of school instruction type on mental health and GI symptoms for youth with GI conditions during the COVID-19 pandemic.
Method: Data were collected from caregivers and patients aged 8 to 17 years with inflammatory bowel disease, celiac disease, and irritable bowel syndrome (N = 146) from September to December 2020. Patients completed measures of depression, anxiety, anger, and GI symptoms; caregivers provided their child's school instruction type (online, hybrid, or in-person). Analyses were conducted to examine the relations of mental health symptoms, GI symptoms, and school instruction type.
Results: Participants generally had mild levels of depressive symptoms (T = 55.50), and anxiety (T = 53.02) and anger (T = 49.92) symptoms were within normal limits. Anxiety and GI symptoms were positively related ( b = 0.14, p < 0.01), and if participants were attending school online, they had worse GI symptoms ( b = 0.46, p < 0.05). However, there was no significant interaction between anxiety and instruction type. Depression and anger were not significantly related to GI symptoms and there were no significant interactions.
Conclusion: For children with GI conditions during the pandemic, as their anxiety symptoms increased, so did their GI symptoms. Further research should examine the long-term effects of virtual learning for those with GI conditions.
{"title":"The Relations Among GI Symptoms, Mental Health, and Online Schooling for Youth With GI Conditions During the COVID-19 Pandemic.","authors":"Abigail S Robbertz, Cecelia I Nelson, James Peugh, Kevin Hommel, Lisa P Armistead, Lindsey L Cohen","doi":"10.1097/DBP.0000000000001429","DOIUrl":"10.1097/DBP.0000000000001429","url":null,"abstract":"<p><strong>Objectives: </strong>For youth with gastrointestinal (GI) conditions, mental health symptoms can exacerbate GI symptoms. In a cyclical fashion, experiencing GI symptoms at school can contribute to depression, anxiety, and embarrassment. This study evaluated the impact of school instruction type on mental health and GI symptoms for youth with GI conditions during the COVID-19 pandemic.</p><p><strong>Method: </strong>Data were collected from caregivers and patients aged 8 to 17 years with inflammatory bowel disease, celiac disease, and irritable bowel syndrome (N = 146) from September to December 2020. Patients completed measures of depression, anxiety, anger, and GI symptoms; caregivers provided their child's school instruction type (online, hybrid, or in-person). Analyses were conducted to examine the relations of mental health symptoms, GI symptoms, and school instruction type.</p><p><strong>Results: </strong>Participants generally had mild levels of depressive symptoms (T = 55.50), and anxiety (T = 53.02) and anger (T = 49.92) symptoms were within normal limits. Anxiety and GI symptoms were positively related ( b = 0.14, p < 0.01), and if participants were attending school online, they had worse GI symptoms ( b = 0.46, p < 0.05). However, there was no significant interaction between anxiety and instruction type. Depression and anger were not significantly related to GI symptoms and there were no significant interactions.</p><p><strong>Conclusion: </strong>For children with GI conditions during the pandemic, as their anxiety symptoms increased, so did their GI symptoms. Further research should examine the long-term effects of virtual learning for those with GI conditions.</p>","PeriodicalId":50215,"journal":{"name":"Journal of Developmental and Behavioral Pediatrics","volume":" ","pages":"e54-e58"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12947231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-18DOI: 10.1097/DBP.0000000000001421
Javiera Ortega, Natalia Vázquez, Maddalen García-Sanchoyerto, Imanol Amayra Caro
Objective: This study aimed to explore family and caregiver's quality of life, identifying psychosocial factors related to it.
Method: A cross-sectional quantitative study was carried out with 153 caregivers of children and adolescents with various neuromuscular diagnosis. Caregivers responded to the PedsQL FIM, PAS, MOS, and FACES III scales.
Results: Medium to low levels of quality of life (QoL) were found in caregivers of children with neuromuscular diseases. Caregivers reported low perceived family resources, but most of them presented good psychological adaptation and social support. QoL differences were found according to child's functional dependence and access to pharmacological treatment. Multiple regression analysis showed a model for Family QoL explained by family resources, caregiver's age, social support, and child's functional dependence.
Conclusion: Families had better levels of QoL because they have a higher perception of their family resources, caregivers are older, have more functional social support, and the child has a higher degree of dependency. Results emphasized the need to adopt a psychological and family approach in the management of neuromuscular diseases.
{"title":"Family and Caregiver Quality of Life in Pediatric Neuromuscular Diseases: Psychosocial and Disease-related Predictors.","authors":"Javiera Ortega, Natalia Vázquez, Maddalen García-Sanchoyerto, Imanol Amayra Caro","doi":"10.1097/DBP.0000000000001421","DOIUrl":"10.1097/DBP.0000000000001421","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to explore family and caregiver's quality of life, identifying psychosocial factors related to it.</p><p><strong>Method: </strong>A cross-sectional quantitative study was carried out with 153 caregivers of children and adolescents with various neuromuscular diagnosis. Caregivers responded to the PedsQL FIM, PAS, MOS, and FACES III scales.</p><p><strong>Results: </strong>Medium to low levels of quality of life (QoL) were found in caregivers of children with neuromuscular diseases. Caregivers reported low perceived family resources, but most of them presented good psychological adaptation and social support. QoL differences were found according to child's functional dependence and access to pharmacological treatment. Multiple regression analysis showed a model for Family QoL explained by family resources, caregiver's age, social support, and child's functional dependence.</p><p><strong>Conclusion: </strong>Families had better levels of QoL because they have a higher perception of their family resources, caregivers are older, have more functional social support, and the child has a higher degree of dependency. Results emphasized the need to adopt a psychological and family approach in the management of neuromuscular diseases.</p>","PeriodicalId":50215,"journal":{"name":"Journal of Developmental and Behavioral Pediatrics","volume":" ","pages":"e59-e65"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-02-13DOI: 10.1097/DBP.0000000000001435
Lingyan Shen, Jiayin Zheng, Lixin Ren
Objective: Although the impact of parental technoference on family dynamics has been increasingly studied, its association with preschoolers' social-emotional development and the underlying mechanism behind the association remain underexplored. This study aimed to examine the relationship between parental technoference and preschoolers' social-emotional development among Chinese families, with coparenting as a potential mediator.
Method: This study involved 207 Chinese families with preschoolers (mean age = 4.72 years). Both mothers and fathers reported on their perceptions of technoference, coparenting quality, and their child's social-emotional development.
Results: Parental technoference was negatively associated with both mother- and father-reported coparenting quality. However, only father-reported coparenting, but not mother-reported coparenting, was significantly related to children's social-emotional development. Analysis of the indirect effects showed that both father-reported supportive and undermining coparenting partially mediated the relationship between parental technoference and certain aspects of children's social-emotional development. By contrast, mother-reported coparenting did not significantly mediate the association between parental technoference and children's social-emotional development.
Conclusion: Our findings highlight the importance of managing parental technoference and strengthening coparenting to promote social-emotional development in Chinese preschool children.
{"title":"Parental Technoference (Technology Interference) and Children's Social-Emotional Development: Coparenting as a Mediator.","authors":"Lingyan Shen, Jiayin Zheng, Lixin Ren","doi":"10.1097/DBP.0000000000001435","DOIUrl":"https://doi.org/10.1097/DBP.0000000000001435","url":null,"abstract":"<p><strong>Objective: </strong>Although the impact of parental technoference on family dynamics has been increasingly studied, its association with preschoolers' social-emotional development and the underlying mechanism behind the association remain underexplored. This study aimed to examine the relationship between parental technoference and preschoolers' social-emotional development among Chinese families, with coparenting as a potential mediator.</p><p><strong>Method: </strong>This study involved 207 Chinese families with preschoolers (mean age = 4.72 years). Both mothers and fathers reported on their perceptions of technoference, coparenting quality, and their child's social-emotional development.</p><p><strong>Results: </strong>Parental technoference was negatively associated with both mother- and father-reported coparenting quality. However, only father-reported coparenting, but not mother-reported coparenting, was significantly related to children's social-emotional development. Analysis of the indirect effects showed that both father-reported supportive and undermining coparenting partially mediated the relationship between parental technoference and certain aspects of children's social-emotional development. By contrast, mother-reported coparenting did not significantly mediate the association between parental technoference and children's social-emotional development.</p><p><strong>Conclusion: </strong>Our findings highlight the importance of managing parental technoference and strengthening coparenting to promote social-emotional development in Chinese preschool children.</p>","PeriodicalId":50215,"journal":{"name":"Journal of Developmental and Behavioral Pediatrics","volume":"47 1","pages":"e7-e12"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-01-08DOI: 10.1097/DBP.0000000000001450
Shruti Mittal, Angela Noone, Sally Asquith, Mai Ku Moua, Kimber Mork, Jason M Fogler, Elizabeth A Diekroger
<p><strong>Case: </strong>Ryan is a 6-year-old boy with a history of eosinophilic esophagitis (EoE) and poor weight gain referred to developmental-behavioral pediatrics (DBP) for attention-deficit/hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). Ryan's mother was concerned about Ryan's defiance and daily emotional outbursts, which could last up to an hour. Ryan's teachers frequently contacted the family due to disruptive behavior, impulsivity, and sneaking food.Ryan was born prematurely at 28 weeks and required nasogastric feeds for 1 month in the NICU. He has a history of reflux requiring proton pump inhibitors and failure to thrive at age 2 (currently at 6% for BMI). At age 4, he was evaluated by pediatric gastroenterology and subsequently diagnosed with EoE. Complete elimination of dairy, wheat, soy, eggs, nuts, and seafood/shellfish was recommended as per standard of care for EoE. The diet was difficult for the family and Ryan to maintain, and Ryan often had tantrums around foods/snacks. He would sneak into the pantry to eat things he was not supposed to, causing significant parent-child conflict. Food restrictions were particularly challenging at school. Ryan would ask classmates for their cheese sticks and cookies; snacks he was not allowed to eat. Despite a 504 plan in place, his teachers were unable to monitor his intake.Parent and teacher behavior rating scales were consistent with ADHD-combined type and ODD. Cognitive and academic testing demonstrated academic underachievement in math and reading; however, these results were thought to be an underrepresentation of his true abilities due to easy distractibility and impulsivity observed during assessments. Behavioral therapy, IEP evaluation, and trial of ADHD medication were recommended.Given his poor weight gain and inability to swallow tablets, a nonstimulant, guanfacine immediate release (IR) was initiated. Guanfacine was helpful, but titration was limited due to daytime sedation. Ryan was placed on homebound services due to frequent EoE flares and concerns that school could not adequately monitor food restrictions.GI recommended elemental formula as his primary source of intake due to nonadherence to diet. Ryan required a gastrostomy tube (g-tube) due to his refusal to drink elemental formula. Although EoE symptoms improved, Ryan had increased oppositional and defiant behaviors with his homebound teacher and parents. An extended-release oral liquid methylphenidate stimulant was started in conjunction with guanfacine and resulted in significant improvement of ADHD symptoms. Ryan experienced weight loss and decreased BMI to 3%. Periactin was initiated to help with appetite and sleep quality.After 3 months, Ryan started feeding therapy and behavioral therapy with a family component. He was also approved for home nursing support and respite hours. Several months later, Ryan endorsed missing his friends and wanting to go back to school. He agreed to sign a behavioral
{"title":"Attention-Deficit/Hyperactivity Disorder and Disruptive Behavior in a Child With Eosinophilic Esophagitis and Failure to Thrive.","authors":"Shruti Mittal, Angela Noone, Sally Asquith, Mai Ku Moua, Kimber Mork, Jason M Fogler, Elizabeth A Diekroger","doi":"10.1097/DBP.0000000000001450","DOIUrl":"10.1097/DBP.0000000000001450","url":null,"abstract":"<p><strong>Case: </strong>Ryan is a 6-year-old boy with a history of eosinophilic esophagitis (EoE) and poor weight gain referred to developmental-behavioral pediatrics (DBP) for attention-deficit/hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). Ryan's mother was concerned about Ryan's defiance and daily emotional outbursts, which could last up to an hour. Ryan's teachers frequently contacted the family due to disruptive behavior, impulsivity, and sneaking food.Ryan was born prematurely at 28 weeks and required nasogastric feeds for 1 month in the NICU. He has a history of reflux requiring proton pump inhibitors and failure to thrive at age 2 (currently at 6% for BMI). At age 4, he was evaluated by pediatric gastroenterology and subsequently diagnosed with EoE. Complete elimination of dairy, wheat, soy, eggs, nuts, and seafood/shellfish was recommended as per standard of care for EoE. The diet was difficult for the family and Ryan to maintain, and Ryan often had tantrums around foods/snacks. He would sneak into the pantry to eat things he was not supposed to, causing significant parent-child conflict. Food restrictions were particularly challenging at school. Ryan would ask classmates for their cheese sticks and cookies; snacks he was not allowed to eat. Despite a 504 plan in place, his teachers were unable to monitor his intake.Parent and teacher behavior rating scales were consistent with ADHD-combined type and ODD. Cognitive and academic testing demonstrated academic underachievement in math and reading; however, these results were thought to be an underrepresentation of his true abilities due to easy distractibility and impulsivity observed during assessments. Behavioral therapy, IEP evaluation, and trial of ADHD medication were recommended.Given his poor weight gain and inability to swallow tablets, a nonstimulant, guanfacine immediate release (IR) was initiated. Guanfacine was helpful, but titration was limited due to daytime sedation. Ryan was placed on homebound services due to frequent EoE flares and concerns that school could not adequately monitor food restrictions.GI recommended elemental formula as his primary source of intake due to nonadherence to diet. Ryan required a gastrostomy tube (g-tube) due to his refusal to drink elemental formula. Although EoE symptoms improved, Ryan had increased oppositional and defiant behaviors with his homebound teacher and parents. An extended-release oral liquid methylphenidate stimulant was started in conjunction with guanfacine and resulted in significant improvement of ADHD symptoms. Ryan experienced weight loss and decreased BMI to 3%. Periactin was initiated to help with appetite and sleep quality.After 3 months, Ryan started feeding therapy and behavioral therapy with a family component. He was also approved for home nursing support and respite hours. Several months later, Ryan endorsed missing his friends and wanting to go back to school. He agreed to sign a behavioral ","PeriodicalId":50215,"journal":{"name":"Journal of Developmental and Behavioral Pediatrics","volume":" ","pages":"e94-e96"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12904215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-11-18DOI: 10.1097/DBP.0000000000001430
Kevin M Simon, Modar Sukkarieh, Emmett Walsh, Leslie Green, Laurie A Gates, Elizabeth A Diekroger, Jason M Fogler
<p><strong>Case: </strong>"JD" (identifying details have been changed), a 15-year-old Afro-Caribbean female sophomore student diagnosed with attention-deficit hyperactivity disorder (ADHD), was referred to an Adolescent Substance Use and Addiction Program after substance use disorder screening indicated a positive result, suggesting significant risk. The screening was part of a routine checkup by her primary care provider after noticeable declines in her academic performance and mood.Previously a consistent student, JD's struggles with inattention, forgetfulness, and organizational challenges had become increasingly apparent. Teachers reported that JD seemed perpetually distracted, disengaged, and frequently excused herself to the bathroom. "It's like I'm there, but not really there," JD explained during an evaluation, describing how disconnected she felt from her surroundings. Moreover, her involvement in extracurricular activities such as the debate club and soccer had waned, changes she vaguely attributed to "lack of energy." JD's mother described the transformation as watching her daughter "slip away into someone unrecognizable. Every day brings a new worry."At home, JD's mother discovered JD vaping and found what appeared to be drug paraphernalia in her backpack. Distraught, she confided the ongoing strain these discoveries placed on the family. This period marked a significant emotional toll on the family, accentuating the urgent need for intervention. The sense of loss felt by JD's family was compounded by their fear of her potential decline into more dangerous behaviors, especially given that JD's maternal uncle died of an unintentional opioid-involved overdose.In the initial consultation, JD was reticent to talk about her substance use but gradually disclosed her regular use of cannabis and nicotine via vaping. JD explained that nicotine temporarily enhanced her focus, whereas cannabis provided relief from overwhelming stress, albeit occasionally accompanied by episodes of paranoia. "Sometimes it feels like it's the only thing that calms things down in my head," JD admitted. She voiced a readiness to quit nicotine but showed ambivalence about changing her cannabis use. Despite the adverse effects, JD perceived these substances as benign when compared with other drugs or alcohol ("weed is natural").Complicating the clinical picture, JD viewed her friends as support pillars, contrary to her parents' beliefs that these relationships exacerbated her substance use. Her parents advocated for a strict regimen of abstinence from all substances and a complete disassociation from her friends. "They think my friends are the problem, but they're not," JD contested.The cultural dimensions of JD's identity significantly influenced her engagement with treatment. JD articulated her desire for a treatment approach that respected her and asked for a clinician who could "see where I'm coming from… someone who understands me, not someone who just wants to c
{"title":"Complex Attention-Deficit Hyperactivity Disorder in a 15-year-old With a Substance Use Disorder.","authors":"Kevin M Simon, Modar Sukkarieh, Emmett Walsh, Leslie Green, Laurie A Gates, Elizabeth A Diekroger, Jason M Fogler","doi":"10.1097/DBP.0000000000001430","DOIUrl":"10.1097/DBP.0000000000001430","url":null,"abstract":"<p><strong>Case: </strong>\"JD\" (identifying details have been changed), a 15-year-old Afro-Caribbean female sophomore student diagnosed with attention-deficit hyperactivity disorder (ADHD), was referred to an Adolescent Substance Use and Addiction Program after substance use disorder screening indicated a positive result, suggesting significant risk. The screening was part of a routine checkup by her primary care provider after noticeable declines in her academic performance and mood.Previously a consistent student, JD's struggles with inattention, forgetfulness, and organizational challenges had become increasingly apparent. Teachers reported that JD seemed perpetually distracted, disengaged, and frequently excused herself to the bathroom. \"It's like I'm there, but not really there,\" JD explained during an evaluation, describing how disconnected she felt from her surroundings. Moreover, her involvement in extracurricular activities such as the debate club and soccer had waned, changes she vaguely attributed to \"lack of energy.\" JD's mother described the transformation as watching her daughter \"slip away into someone unrecognizable. Every day brings a new worry.\"At home, JD's mother discovered JD vaping and found what appeared to be drug paraphernalia in her backpack. Distraught, she confided the ongoing strain these discoveries placed on the family. This period marked a significant emotional toll on the family, accentuating the urgent need for intervention. The sense of loss felt by JD's family was compounded by their fear of her potential decline into more dangerous behaviors, especially given that JD's maternal uncle died of an unintentional opioid-involved overdose.In the initial consultation, JD was reticent to talk about her substance use but gradually disclosed her regular use of cannabis and nicotine via vaping. JD explained that nicotine temporarily enhanced her focus, whereas cannabis provided relief from overwhelming stress, albeit occasionally accompanied by episodes of paranoia. \"Sometimes it feels like it's the only thing that calms things down in my head,\" JD admitted. She voiced a readiness to quit nicotine but showed ambivalence about changing her cannabis use. Despite the adverse effects, JD perceived these substances as benign when compared with other drugs or alcohol (\"weed is natural\").Complicating the clinical picture, JD viewed her friends as support pillars, contrary to her parents' beliefs that these relationships exacerbated her substance use. Her parents advocated for a strict regimen of abstinence from all substances and a complete disassociation from her friends. \"They think my friends are the problem, but they're not,\" JD contested.The cultural dimensions of JD's identity significantly influenced her engagement with treatment. JD articulated her desire for a treatment approach that respected her and asked for a clinician who could \"see where I'm coming from… someone who understands me, not someone who just wants to c","PeriodicalId":50215,"journal":{"name":"Journal of Developmental and Behavioral Pediatrics","volume":"47 1","pages":"e91-e93"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12904219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-08DOI: 10.1097/DBP.0000000000001418
Emily Hamovitch, Tharani Raveendran, Eyal Cohen, Astrid Guttmann, Azmina Altaf, Christina Diong, Andrea Evans, Therese A Stukel, Magdalena Janus, Natasha R Saunders
Objective: We sought to measure whether receipt of an enhanced 18-month well-baby visit with use of a developmental screening tool versus a routine 18-month well-baby visit (which typically involves developmental surveillance without screening) is associated with time to identification of developmental delays.
Method: We conducted a cohort study of children (17-22 months) in Ontario who received an 18-month well-baby visit (March 2020‒March 2022), followed to September 2022 using linked health administrative datasets. Visits were categorized as enhanced (n = 83,554) or routine (n = 15,723). The outcome was the identification of a developmental delay within 6 months (early) and more than 6 months after (late) the 18-month visit. Piecewise Cox proportional hazards models estimated hazard ratios (aHR) adjusted for child, maternal, and physician factors, comparing developmental delay diagnosis by visit type.
Results: Children who received an enhanced visit were slightly older, had a lower representation in the most deprived group, and a higher percentage of patients with pediatricians as their usual provider of care. After adjustment, children with enhanced compared with routine visits were more likely to have developmental delays detected in the early period (aHR 1.19 95% CI 1.11‒1.28) but not in the late period following the well-baby visit.
Conclusion: Enhanced visits are associated with earlier identification of developmental delays compared with routine visits in the 6 months following the 18-month well-baby visit. Enhanced developmental monitoring using screening tools may facilitate earlier recognition of developmental concerns.
目的:我们试图衡量接受使用发育筛查工具的18个月增强健康婴儿访视与常规18个月健康婴儿访视(通常包括发育监测而不进行筛查)是否与识别发育迟缓的时间有关。方法:我们对安大略省(17-22个月)的儿童进行了一项队列研究,这些儿童接受了为期18个月的健康婴儿访问(2020年3月至2022年3月),随后至2022年9月使用相关的卫生管理数据集。就诊分为强化就诊(n = 83554)和常规就诊(n = 15723)。结果是在6个月内(早期)和超过6个月后(晚期)18个月的访问中确定发育迟缓。分段Cox比例风险模型估计了儿童、母亲和医生因素调整后的风险比(aHR),比较了不同就诊类型的发育迟缓诊断。结果:接受强化访问的儿童年龄稍大,在最贫困群体中的代表性较低,并且儿科医生作为其通常护理提供者的患者比例较高。调整后,与常规访视相比,增强的儿童更有可能在早期发现发育迟缓(aHR 1.19, 95% CI 1.11-1.28),但在健康婴儿访视后的后期没有发现发育迟缓。结论:在18个月健康婴儿访视后的6个月内,与常规访视相比,加强访视与早期发现发育迟缓有关。使用筛查工具加强发育监测可能有助于早期识别发育问题。
{"title":"Effectiveness of Enhanced Developmental Screening at 18 Months to Identify Developmental Delays.","authors":"Emily Hamovitch, Tharani Raveendran, Eyal Cohen, Astrid Guttmann, Azmina Altaf, Christina Diong, Andrea Evans, Therese A Stukel, Magdalena Janus, Natasha R Saunders","doi":"10.1097/DBP.0000000000001418","DOIUrl":"10.1097/DBP.0000000000001418","url":null,"abstract":"<p><strong>Objective: </strong>We sought to measure whether receipt of an enhanced 18-month well-baby visit with use of a developmental screening tool versus a routine 18-month well-baby visit (which typically involves developmental surveillance without screening) is associated with time to identification of developmental delays.</p><p><strong>Method: </strong>We conducted a cohort study of children (17-22 months) in Ontario who received an 18-month well-baby visit (March 2020‒March 2022), followed to September 2022 using linked health administrative datasets. Visits were categorized as enhanced (n = 83,554) or routine (n = 15,723). The outcome was the identification of a developmental delay within 6 months (early) and more than 6 months after (late) the 18-month visit. Piecewise Cox proportional hazards models estimated hazard ratios (aHR) adjusted for child, maternal, and physician factors, comparing developmental delay diagnosis by visit type.</p><p><strong>Results: </strong>Children who received an enhanced visit were slightly older, had a lower representation in the most deprived group, and a higher percentage of patients with pediatricians as their usual provider of care. After adjustment, children with enhanced compared with routine visits were more likely to have developmental delays detected in the early period (aHR 1.19 95% CI 1.11‒1.28) but not in the late period following the well-baby visit.</p><p><strong>Conclusion: </strong>Enhanced visits are associated with earlier identification of developmental delays compared with routine visits in the 6 months following the 18-month well-baby visit. Enhanced developmental monitoring using screening tools may facilitate earlier recognition of developmental concerns.</p>","PeriodicalId":50215,"journal":{"name":"Journal of Developmental and Behavioral Pediatrics","volume":" ","pages":"e37-e44"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12904248/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145016566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-10-13DOI: 10.1097/DBP.0000000000001427
Francilena Ribeiro Bessa, Katia Virgínia Viana-Cardoso, José Davi Nunes Martins, Rafaela Silva Moreira, Claudia Regina Lindgren Alves, Lívia de Castro Magalhães
Objective: To estimate the frequency of suspected neurodevelopmental delays (NDD) and to investigate the measurement properties and usability of the Survey of Well-Being of Young Children-Brazilian version (SWYC-BR).
Methods: We conducted a cross-sectional study in Basic Health care Units in Northeastern Brazil. The participants were 645 mothers/caregivers of children between 2 and 65 months of age who completed the SWYC-BR and a socioeconomic questionnaire. We estimated the frequency of suspected NDD using the SWYC-BR, assessed the respondents' experience with the questionnaire, and examined test-retest reliability and internal consistency of the SWYC-BR items, as well as the construct validity of the Developmental Milestones questionnaire (DM-SWYC).
Results: The sample consisted primarily of families residing in urban areas and belonging to very low socioeconomic classes. The frequency of suspected NDD was 37.9%. The internal consistency of the SWYC-BR ranged from 0.56 to 0.97, and the test-retest reliability of the items was high (>0.75). Significant associations with risk factors for developmental delays confirmed the construct validity of the DM-SWYC. Most mothers/caregivers found the SWYC-BR easy to respond (85.7%) and enjoyed responding to the questions (95.8%).
Conclusion: The high frequency of suspected NDD highlights the need for special attention to early child development. The SWYC-BR was well accepted, and its measurement properties were confirmed, demonstrating its feasibility in identifying children requiring closer primary health care monitoring.
{"title":"Screening for Developmental Delays in Primary Health Care in Northeastern Brazil.","authors":"Francilena Ribeiro Bessa, Katia Virgínia Viana-Cardoso, José Davi Nunes Martins, Rafaela Silva Moreira, Claudia Regina Lindgren Alves, Lívia de Castro Magalhães","doi":"10.1097/DBP.0000000000001427","DOIUrl":"10.1097/DBP.0000000000001427","url":null,"abstract":"<p><strong>Objective: </strong>To estimate the frequency of suspected neurodevelopmental delays (NDD) and to investigate the measurement properties and usability of the Survey of Well-Being of Young Children-Brazilian version (SWYC-BR).</p><p><strong>Methods: </strong>We conducted a cross-sectional study in Basic Health care Units in Northeastern Brazil. The participants were 645 mothers/caregivers of children between 2 and 65 months of age who completed the SWYC-BR and a socioeconomic questionnaire. We estimated the frequency of suspected NDD using the SWYC-BR, assessed the respondents' experience with the questionnaire, and examined test-retest reliability and internal consistency of the SWYC-BR items, as well as the construct validity of the Developmental Milestones questionnaire (DM-SWYC).</p><p><strong>Results: </strong>The sample consisted primarily of families residing in urban areas and belonging to very low socioeconomic classes. The frequency of suspected NDD was 37.9%. The internal consistency of the SWYC-BR ranged from 0.56 to 0.97, and the test-retest reliability of the items was high (>0.75). Significant associations with risk factors for developmental delays confirmed the construct validity of the DM-SWYC. Most mothers/caregivers found the SWYC-BR easy to respond (85.7%) and enjoyed responding to the questions (95.8%).</p><p><strong>Conclusion: </strong>The high frequency of suspected NDD highlights the need for special attention to early child development. The SWYC-BR was well accepted, and its measurement properties were confirmed, demonstrating its feasibility in identifying children requiring closer primary health care monitoring.</p>","PeriodicalId":50215,"journal":{"name":"Journal of Developmental and Behavioral Pediatrics","volume":" ","pages":"e66-e73"},"PeriodicalIF":2.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}